Fusion Antibodies plc (FAB.L)
GBp 6.55
(0.77%)
GBp 6.55
(0.77%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.04 GBP | 59.82% |
| 2022 | -0.10 GBP | -115.55% |
| 2021 | -0.05 GBP | 57.91% |
| 2020 | -0.11 GBP | -248.1% |
| 2019 | -0.03 GBP | 44.76% |
| 2018 | -0.06 GBP | -31.8% |
| 2017 | -0.04 GBP | -903.7% |
| 2016 | 0.01 GBP | -89.66% |
| 2015 | 0.05 GBP | 1438.46% |
| 2014 | -0.00 GBP | 23.53% |
| 2013 | -0.01 GBP | 75.94% |
| 2012 | -0.02 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 FY | - GBP | 59.82% |
| 2023 Q2 | -0.03 GBP | 0.0% |
| 2023 Q4 | -0.02 GBP | 0.0% |
| 2022 Q4 | -0.06 GBP | 0.0% |
| 2022 FY | - GBP | -115.55% |
| 2022 Q2 | -0.04 GBP | 0.0% |
| 2021 FY | - GBP | 57.91% |
| 2021 Q4 | -0.02 GBP | 0.0% |
| 2021 Q2 | -0.02 GBP | 0.0% |
| 2020 Q2 | -0.02 GBP | 0.0% |
| 2020 Q4 | -0.09 GBP | 0.0% |
| 2020 FY | - GBP | -248.1% |
| 2019 Q4 | -0.01 GBP | 0.0% |
| 2019 Q2 | -0.02 GBP | 0.0% |
| 2019 FY | - GBP | 44.76% |
| 2018 FY | - GBP | -31.8% |
| 2018 Q4 | -0.02 GBP | -65.03% |
| 2018 Q3 | -0.01 GBP | 57.44% |
| 2018 Q2 | -0.03 GBP | -216.98% |
| 2018 Q1 | -0.01 GBP | 63.19% |
| 2017 Q2 | -0.01 GBP | -971.43% |
| 2017 Q4 | -0.03 GBP | 0.0% |
| 2017 FY | - GBP | -903.7% |
| 2017 Q1 | 0.00 GBP | 0.0% |
| 2016 Q1 | 0.01 GBP | 0.0% |
| 2016 FY | - GBP | -89.66% |
| 2016 Q4 | 0.00 GBP | 0.0% |
| 2016 Q3 | 0.00 GBP | 0.0% |
| 2015 Q4 | 0.01 GBP | 0.0% |
| 2015 Q3 | 0.01 GBP | 1410.0% |
| 2015 FY | - GBP | 1438.46% |
| 2015 Q2 | -0.00 GBP | 0.0% |
| 2015 Q1 | -0.00 GBP | 0.0% |
| 2014 Q4 | -0.00 GBP | 0.0% |
| 2014 Q3 | -0.00 GBP | 0.0% |
| 2014 FY | - GBP | 23.53% |
| 2013 FY | - GBP | 75.94% |
| 2012 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|